Search Medical Condition
Please enter condition
Please choose location from dropdown

Common Cold Clinical Trials

A listing of Common Cold medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (36) clinical trials

Currently it is challenging to distinguish viral infections that cannot be treated with antibiotics from bacterial infections which do respond to antibiotics. Clinical Research Associates in Nashville, TN is conducting a research study to test a diagnostic device. This device is designed to identify your body's immune response to a ...

Phase N/A

Are you experiencing symptoms of a cold, such as a runny nose, cough, or sore throat that have started within the last 40 hours? The Clinical Research Center in West St. Louis County is conducting a research study to evaluate an antiviral medication for the common cold.  The study consists ...

Phase N/A

The Centers for Disease Control and Prevention (CDC) reports: Common colds are the main reason that children miss school and adults miss work Each year in the United States, there are millions of cases of the common cold Adults have an average of 2-3 colds per year, and children have ...

Phase N/A

Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units

Background, Literature Survey and Justification of The Study 1.1. Introduction -lactams efficacy depends primarily from the time interval during which the plasma concentration remains above the minimal inhibitory concentration (MIC) of the antibiotic against the target organism(s) (Craig, 1998). It is generally accepted that the free concentration of the antibiotic ...

Phase N/A

Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)

The purpose of this study is to validate the diagnostic accuracy of a novel host-response based diagnostic tool for differentiating between bacterial and viral etiologies in adult patients aged 18 years and older with clinical suspicion of lower respiratory tract infections (LRTI)

Phase N/A

Diagnostic Accuracy of a Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients

This is a prospective clinical validation study of a novel regulatory approved (CE-IVD) diagnostic assay called ImmunoXpert that will enroll 1222 pediatric patients. The study aims to externally validate the tool's diagnostic accuracy and estimate the potential improvement in health and economic outcomes following the usage of ImmunoXpert. Additionally, statistical ...

Phase N/A

Exploratory Study of Intrapulmonary Microdosing of Gram-negative Optical Imaging Detection Probe

The primary objective of this study is to deliver a BAC TWO microdose to 3 ventilated controls and 9 patients to assess the imaging parameters of BAC TWO over human autofluorescence and to assess if gram-negative bacteria can be detected in vivo in situ within the distal lung. The primary ...

Phase N/A

A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care Settings

In this proposed acute care project, the investigators will compare a package consisting of education for providers using existing materials from CDC's GetSmart campaign adapted for the acute care setting led by a physician champion at each site (the adapted intervention), to a more intensive intervention that incorporates adapted GetSmart ...

Phase N/A

Targeted AntiBiotics for Chronic Obstructive Pulmonary Disease

P. aeruginosa represents a potentially significant cause of acute exacerbation of COPD (AECOPD) and is possibly associated with significant morbidity and mortality. Despite this, the role of P. aeruginosa in the course of COPD is less well characterized, and evidence based guidelines for management and treatment of the bacteria are ...

Phase

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine Isoniazid in HIV+ Patients

Single-arm, single-center, Phase I/II clinical trial, in two Groups. Individuals with HIV infection taking EFV and two nucleoside reverse transcriptase inhibitors (NRTI) who have undetectable HIV viral load and an indication for treatment of LTBI, will be switched to DTG with tenofovir/emtricitabine for at least two months and will receive ...

Phase